tiprankstipranks
Northwest Biotherapeutics (NWBO)
OTHER OTC:NWBO

Northwest Biotherapeutics (NWBO) Stock Price & Analysis

365 Followers

NWBO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.40 - $1.09
Previous Close$0.48
Volume1.62M
Average Volume (3M)1.79M
Market Cap
$574.82M
Enterprise Value$605.48M
Total Cash (Recent Filing)$2.13M
Total Debt (Recent Filing)$32.79M
Price to Earnings (P/E)-8.4
Beta-0.02
May 16, 2018
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding1,189,970,308
10 Day Avg. Volume1,753,497
30 Day Avg. Volume1,787,029
Standard Deviation0.26
R-Squared0.02
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)-8.49
Price to Sales (P/S)297.52
Price to Cash Flow (P/CF)-8.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue556.51
Enterprise Value/Gross Profit313.39
Enterprise Value/Ebitda-10.84
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

9.78%0.01%0.04%90.17%
0.04% Other Institutional Investors
90.17% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

NWBO FAQ

What was Northwest Biotherapeutics’s price range in the past 12 months?
Northwest Biotherapeutics lowest stock price was $0.40 and its highest was $1.09 in the past 12 months.
    What is Northwest Biotherapeutics’s market cap?
    Currently, no data Available
    When is Northwest Biotherapeutics’s upcoming earnings report date?
    Northwest Biotherapeutics’s upcoming earnings report date is May 16, 2018 which is 2143 days ago.
      How were Northwest Biotherapeutics’s earnings last quarter?
      Currently, no data Available
      Is Northwest Biotherapeutics overvalued?
      According to Wall Street analysts Northwest Biotherapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Northwest Biotherapeutics pay dividends?
        Northwest Biotherapeutics does not currently pay dividends.
        What is Northwest Biotherapeutics’s EPS estimate?
        Northwest Biotherapeutics’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Northwest Biotherapeutics have?
        Northwest Biotherapeutics has 1,189,970,300 shares outstanding.
          What happened to Northwest Biotherapeutics’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Northwest Biotherapeutics?
          Among the largest hedge funds holding Northwest Biotherapeutics’s share is Fisher Asset Management LLC. It holds Northwest Biotherapeutics’s shares valued at N/A.
            ---

            Company Description

            Northwest Biotherapeutics

            Northwest Biotherapeutics, Inc. is a clinical stage biotechnology company. The firm engages in the development of cancer vaccines designed to treat solid tumor cancers. It also offers a platform technology for DCVax dendritic cell-based vaccines. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Advaxis
            Agenus
            Onconova Therapeutics
            Brainstorm Cell Therapeutics
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis